MENU
APR 29, 2021
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

OncomineWorld 2021: A virtual NGS education meeting


In 2020, we brought thousands of professionals together for our inaugural, virtual next-generation sequencing (NGS) education meetings. This year, we are back with new live presentations on April 29th!

Join us to hear from pathology labs on important topics like hot and emerging biomarker testing, such as genomic instability, and new user experiences with the Ion Torrent Genexus NGS System in solid and hematologic tumor clinical research.

What can you expect from OncomineWorld 2021?

In addition to our great lineup of live presentations, you will also have access to all that the OncomineWorld universe has to offer -

  •  Dozens of on-demand educational presentations from our 2020 meetings
  • Demonstrations of the Ion Torrent Genexus System, recorded from a Thermo Fisher Scientific lab
  • The latest NGS research from Thermo Fisher Scientific with new posters in the Poster Hall
  • New content in the Precision Oncology Hall, with all about why and how genomic profiling for precision oncology should be done in-house, locally and close to patients

Earn CE credits from on-demand or live presentations and explore our virtual laboratories to learn about the new world of easy and fast NGS – the Genexus System. Explore NGS application areas like emerging NSCLC biomarkers, comprehensive genomic profiling (CGP), liquid biopsy research, and hemato-oncology research.

 

Sincerely,

Your Thermo Fisher Scientific Oncology NGS team

 

For Research Use Only. Not for use in diagnostic procedures.


Show Resources
You May Also Like
APR 20, 2021 5:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
APR 20, 2021 5:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
APR 19, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 19, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 10th Annual Genetics Virtual Week held on April 19-21, 2022! Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expe...
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
Agenda
  • Comprehensive Assay Plus evaluation data
    APR 29, 2021 12:00 PM +08
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Comprehensive Assay Plus evaluation data
    Dr. Tony Lim
    Associate Professor, Singapore General Hospital, Oncomine
    Continuing Education: Florida CE | P.A.C.E. CE
  • Current and upcoming pharma collaboration and IVD strategy
    APR 29, 2021 12:05 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Current and upcoming pharma collaboration and IVD strategy
    Garret Hampton
    President, Clinical Next Generation Sequencing, Thermo Fisher Scientific
    Continuing Education: Florida CE | P.A.C.E. CE
  • Data sharing on Oncomine Myeloid Research Assay GX
    APR 29, 2021 12:25 PM +08
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Data sharing on Oncomine Myeloid Research Assay GX
    Dr. Neeraj Arora
    Unipath Specialty Laboratory
    Continuing Education: Florida CE | P.A.C.E. CE
  • Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
    APR 29, 2021 1:15 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
    Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
    Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
  • TBD
    APR 29, 2021 1:15 PM +08
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    TBD
    Speaker First & Last Name, Credentials
    Job Title, Institution/Company
  • TBD
    APR 29, 2021 1:35 PM +08
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    TBD
    Speaker First & Last Name, Credentials
    Job Title, Institution/Company
  • Genexus System and Genexus Software Demo
    APR 29, 2021 2:10 PM +08
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Genexus System and Genexus Software Demo
    Speaker First & Last Name, Credentials
    Job Title, Institution/Company
  • Genexus System and Genexus Software Demo
    APR 29, 2021 2:10 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Genexus System and Genexus Software Demo
    Speaker First & Last Name, Credentials
    Job Title, Institution/Company
  • OPA on Genexus
    APR 29, 2021 2:35 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OPA on Genexus
    Dr. Leomar Ballester
    University of Texas Health
    Continuing Education: Florida CE | P.A.C.E. CE
  • The value of the Genexus System in pathology extended for use in SARS-CoV-2 sequencing
    APR 29, 2021 3:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The value of the Genexus System in pathology extended for use in SARS-CoV-2 sequencing
    Nicola Normanno, MD
    Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
    Continuing Education: Florida CE | P.A.C.E. CE
  • NSCLC molecular profiling: An NGS based approach using Oncomine Solutions
    APR 29, 2021 3:35 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    NSCLC molecular profiling: An NGS based approach using Oncomine Solutions
    Artur Kowalik, Ph.D.
    Head of Department of Molecular Diagnostics, Holycross Cancer Center
  • TBD
    APR 29, 2021 4:20 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    TBD
    Speaker First & Last Name, Credentials
    Job Title, Institution/Company
  • TBD
    APR 29, 2021 4:40 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    TBD
    Speaker First & Last Name, Credentials
    Job Title, Institution/Company
  • Genexus System and Genexus Software Demo
    APR 29, 2021 5:15 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Genexus System and Genexus Software Demo
    Speaker First & Last Name, Credentials
    Job Title, Institution/Company
  • Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
    OCT 22, 2020 1:35 PM PDT
    Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
    Jane Bayani, PhD
    Principal Research Scientist, Ontario Institute for Cancer Research
  • Utilizing the Genexus System to Detect Complex Genetic Variants in Human Tissue Specimens
    OCT 22, 2020 1:15 PM PDT
    Utilizing the Genexus System to Detect Complex Genetic Variants in Human Tissue Specimens
    Craig Mackinnon, MD, PhD
    Director, Genomic Diagnostics and Bioinformatics - Professor, Department of Pathology, University of Alabama at Birmingham
  • Clinical impact of Next-Generation Sequencing (NGS) Testing: A hematopathologist's perspective
    OCT 22, 2020 12:25 PM PDT
    Clinical impact of Next-Generation Sequencing (NGS) Testing: A hematopathologist's perspective
    Megan S. Lim, MD, PhD
    Director of the Division of Hematopathology, Hospital of the University of Pennsylvania
  • Molecular Testing of NSCLC Biopsies: Making mountains out of molehills
    OCT 22, 2020 12:05 PM PDT
    Molecular Testing of NSCLC Biopsies: Making mountains out of molehills
    Carmen Kletecka, MD, FCAP, FASCP
    Medical Director, Molecular Oncology Diagnostics Laboratory - U.S. Department of Veterans Affairs
  • First Experiences with Oncomine™ Comprehensive Assay Plus for comprehensive genomic profiling
    OCT 22, 2020 4:40 PM CEST
    First Experiences with Oncomine™ Comprehensive Assay Plus for comprehensive genomic profiling
    Ines Raineri, MD
    Staff Pathologist, Institute for Pathology medica AG
  • NGS evolution in Solid Tumours, from S5-XL to Genexus
    OCT 22, 2020 4:20 PM CEST
    NGS evolution in Solid Tumours, from S5-XL to Genexus
    Javier Hernandez-Losa, PhD
    Director of Molecular Biology Laboratory, Department of Pathology - Vall d´Hebron Hospital
  • Next Generation rEvolution in Myeloid Neoplasms clinical research
    OCT 22, 2020 3:35 PM CEST
    Next Generation rEvolution in Myeloid Neoplasms clinical research
    Giada Rotunno, PhD
    Research Scientist, University of Florence
  • NGS for precision oncology in solid tumors: from research to clinical practice
    OCT 22, 2020 3:05 PM CEST
    NGS for precision oncology in solid tumors: from research to clinical practice
    Nicola Normanno, MD
    Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
  • Latest Developments with the Genexus System
    OCT 22, 2020 1:35 PM SGT
    Latest Developments with the Genexus System
    Dr. Jose Luis Costa
    Medical Director, Thermo Fisher Scientific
  • OCA Plus DNA evaluation for comprehensive genomic profiling in clinical research
    OCT 22, 2020 1:15 PM SGT
    OCA Plus DNA evaluation for comprehensive genomic profiling in clinical research
    Ahwon Lee, MD, PhD
    Professor, Catholic University of Korea and Pathologist, Seoul St. Mary's Hospital
  • The role of PARPis and HRD testing in advanced ovarian cancer
    OCT 22, 2020 12:25 PM SGT
    The role of PARPis and HRD testing in advanced ovarian cancer
    Natalie Ngoi, MBBS, MMed, MRCP
    Associate Consultant, National University Cancer Institute, Singapore
  • Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population - a cost-effectiveness analysis
    OCT 22, 2020 12:05 PM SGT
    Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population - a cost-effectiveness analysis
    Aaron Tan, PhD
    Oncology Fellow, Resident Physician, National Cancer Centre, Singapore
  • Haemato-Oncology Applications of BCR Immune Repertoire Sequencing
    MAY 14, 2020 7:05 PM EDT
    Haemato-Oncology Applications of BCR Immune Repertoire Sequencing
    Timothy Looney, PhD
    Associate Director, Bioinformatics; Clinical Next-Generation Sequencing
  • Genomic profiling of prostate cancer cells from urine using Oncomine Pan Cancer Cell Free Assay
    MAY 14, 2020 6:40 PM EDT
    Genomic profiling of prostate cancer cells from urine using Oncomine Pan Cancer Cell Free Assay
    Jane Bayani, PhD
    Principal Research Scientist, Ontario Institute for Cancer Research
  • Experience with Oncomine Myeloid Research Assay
    MAY 14, 2020 6:05 PM EDT
    Experience with Oncomine Myeloid Research Assay
    Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
    Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
  • First experience with the Ion Torrent Genexus Workflow
    MAY 14, 2020 5:40 PM EDT
    First experience with the Ion Torrent Genexus Workflow
    Kojo Elenitoba-Johnson, MD
    Director, Center for Personalized Diagnostics Director, Division of Precision and Computational Diagnostics, University of Pennsylvania Perelman School of Medicine
  • Molecular Profiling for Treatment Guidance of Hematologic Malignancies by Next Generation Sequencing
    MAY 14, 2020 5:00 PM EDT
    Molecular Profiling for Treatment Guidance of Hematologic Malignancies by Next Generation Sequencing
    Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
    Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
  • Lymphoid and Myeloid NGS Molecular Characterization - Assessing the Journey to Answers
    MAY 14, 2020 4:40 PM CEST
    Lymphoid and Myeloid NGS Molecular Characterization - Assessing the Journey to Answers
    Marianne Grantham
    Clinical Scientist, Head of Cytogenetics and Molecular Haematology, Barts Health NHS Trust The Royal London Hospital
  • Advantages and Challenges of Broad Molecular Profiling
    MAY 14, 2020 4:15 PM CEST
    Advantages and Challenges of Broad Molecular Profiling
    Ilaria Alborelli, PhD
    Scientific Operations Manager, Molecular Assay Development Unit Institute of Medical Genetics and Pathology, University Hospital of Basel - Switzerland
  • Genexus - A Major Step Forward in Diagnostic NGS
    MAY 14, 2020 3:30 PM CEST
    Genexus - A Major Step Forward in Diagnostic NGS
    Michael Hummel, PhD
    Head of Molecular Pathology, Charité - Universitätsmedizin Berlin, Institute of Pathology, Germany
  • Analysis of Solid Tumor Genomic Landscape in Liquid Biopsy
    MAY 14, 2020 3:00 PM CEST
    Analysis of Solid Tumor Genomic Landscape in Liquid Biopsy
    Nicola Normanno, MD
    Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
  • Emerging Biomarkers in Non-small Cell Lung Cancer
    MAY 14, 2020 3:00 PM CEST
    Emerging Biomarkers in Non-small Cell Lung Cancer
    Luca Quagliata, PhD
    Global Head of Medical Affairs, Clinical NGS and Oncology Division, Thermo Fisher Scientific
  • Oncomine Precision Assay on Ion Torrent Genexus System for liquid biopsy sample
    MAY 14, 2020 2:40 PM SGT
    Oncomine Precision Assay on Ion Torrent Genexus System for liquid biopsy sample
    Siew-Kee (Amanda) Low, PhD
    Group Leader for Cancer Neoantigen Vaccine Development Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research (JFCR)
  • First Experience from New World of Easy NGS - Ion Torrent Genexus Workflow
    MAY 14, 2020 2:15 PM SGT
    First Experience from New World of Easy NGS - Ion Torrent Genexus Workflow
    Philip Jermann, PhD
    Director of the Molecular Assay Development Unit, Institute of Pathology and Medical Genetics of Basel
  • NATA Accreditation of Next Generation Sequencing for CDx Testing
    MAY 14, 2020 1:25 PM SGT
    NATA Accreditation of Next Generation Sequencing for CDx Testing
    Luke Hesson, PhD, FFScRCPA
    Laboratory Director, KCCG Sequencing Facility & Cancer Diagnostics​, Australia
  • Test Validation in Medical Laboratories: the Australian Perspective
    MAY 14, 2020 1:25 PM SGT
    Test Validation in Medical Laboratories: the Australian Perspective
    Luke Hesson, PhD, FFScRCPA
    Laboratory Director, KCCG Sequencing Facility & Cancer Diagnostics​, Australia
  • Implementation of Multigene Testing for 1st line NSCLC - A Malaysian initiative
    MAY 14, 2020 1:00 PM SGT
    Implementation of Multigene Testing for 1st line NSCLC - A Malaysian initiative
    Dr. Pathmanathan Rajadurai, MBBS, FRCPA, FRCPath
    Senior Consultant Pathologist and Laboratory Director
  • Live Session 1
    • Part 1: NGS in Precision Oncology - General Education
    • Implementation of Multigene Testing for 1st line NSCLC - A Malaysian initiative
      MAY 14, 2020 1:00 PM SGT
      Implementation of Multigene Testing for 1st line NSCLC - A Malaysian initiative
      Dr. Pathmanathan Rajadurai, MBBS, FRCPA, FRCPath
      Senior Consultant Pathologist and Laboratory Director
    • Test Validation in Medical Laboratories: the Australian Perspective
      MAY 14, 2020 1:25 PM SGT
      Test Validation in Medical Laboratories: the Australian Perspective
      Luke Hesson, PhD, FFScRCPA
      Laboratory Director, KCCG Sequencing Facility & Cancer Diagnostics​, Australia
    • NATA Accreditation of Next Generation Sequencing for CDx Testing
      MAY 14, 2020 1:25 PM SGT
      NATA Accreditation of Next Generation Sequencing for CDx Testing
      Luke Hesson, PhD, FFScRCPA
      Laboratory Director, KCCG Sequencing Facility & Cancer Diagnostics​, Australia
    • Part 2: Experiences with Oncomine Solutions for Clinical Research
    • First Experience from New World of Easy NGS - Ion Torrent Genexus Workflow
      MAY 14, 2020 2:15 PM SGT
      First Experience from New World of Easy NGS - Ion Torrent Genexus Workflow
      Philip Jermann, PhD
      Director of the Molecular Assay Development Unit, Institute of Pathology and Medical Genetics of Basel
    • Oncomine Precision Assay on Ion Torrent Genexus System for liquid biopsy sample
      MAY 14, 2020 2:40 PM SGT
      Oncomine Precision Assay on Ion Torrent Genexus System for liquid biopsy sample
      Siew-Kee (Amanda) Low, PhD
      Group Leader for Cancer Neoantigen Vaccine Development Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research (JFCR)
  • Live Session 2
    • Part 1: NGS IN PRECISION ONCOLOGY - GENERAL EDUCATION
    • Analysis of Solid Tumor Genomic Landscape in Liquid Biopsy
      MAY 14, 2020 3:00 PM CEST
      Analysis of Solid Tumor Genomic Landscape in Liquid Biopsy
      Nicola Normanno, MD
      Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
    • Part 1: NGS in Precision Oncology - General Education
    • Emerging Biomarkers in Non-small Cell Lung Cancer
      MAY 14, 2020 3:00 PM CEST
      Emerging Biomarkers in Non-small Cell Lung Cancer
      Luca Quagliata, PhD
      Global Head of Medical Affairs, Clinical NGS and Oncology Division, Thermo Fisher Scientific
    • Part 2: Experiences with Oncomine Solutions for Clinical Research
    • Genexus - A Major Step Forward in Diagnostic NGS
      MAY 14, 2020 3:30 PM CEST
      Genexus - A Major Step Forward in Diagnostic NGS
      Michael Hummel, PhD
      Head of Molecular Pathology, Charité - Universitätsmedizin Berlin, Institute of Pathology, Germany
    • Advantages and Challenges of Broad Molecular Profiling
      MAY 14, 2020 4:15 PM CEST
      Advantages and Challenges of Broad Molecular Profiling
      Ilaria Alborelli, PhD
      Scientific Operations Manager, Molecular Assay Development Unit Institute of Medical Genetics and Pathology, University Hospital of Basel - Switzerland
    • Lymphoid and Myeloid NGS Molecular Characterization - Assessing the Journey to Answers
      MAY 14, 2020 4:40 PM CEST
      Lymphoid and Myeloid NGS Molecular Characterization - Assessing the Journey to Answers
      Marianne Grantham
      Clinical Scientist, Head of Cytogenetics and Molecular Haematology, Barts Health NHS Trust The Royal London Hospital
  • Live Session 3
    • Part 1: NGS in Precision Oncology - General Education
    • Molecular Profiling for Treatment Guidance of Hematologic Malignancies by Next Generation Sequencing
      MAY 14, 2020 5:00 PM EDT
      Molecular Profiling for Treatment Guidance of Hematologic Malignancies by Next Generation Sequencing
      Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
      Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
    • Part 2: Experiences with Oncomine Solutions for Clinical Research
    • First experience with the Ion Torrent Genexus Workflow
      MAY 14, 2020 5:40 PM EDT
      First experience with the Ion Torrent Genexus Workflow
      Kojo Elenitoba-Johnson, MD
      Director, Center for Personalized Diagnostics Director, Division of Precision and Computational Diagnostics, University of Pennsylvania Perelman School of Medicine
    • Experience with Oncomine Myeloid Research Assay
      MAY 14, 2020 6:05 PM EDT
      Experience with Oncomine Myeloid Research Assay
      Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
      Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
    • Genomic profiling of prostate cancer cells from urine using Oncomine Pan Cancer Cell Free Assay
      MAY 14, 2020 6:40 PM EDT
      Genomic profiling of prostate cancer cells from urine using Oncomine Pan Cancer Cell Free Assay
      Jane Bayani, PhD
      Principal Research Scientist, Ontario Institute for Cancer Research
    • Haemato-Oncology Applications of BCR Immune Repertoire Sequencing
      MAY 14, 2020 7:05 PM EDT
      Haemato-Oncology Applications of BCR Immune Repertoire Sequencing
      Timothy Looney, PhD
      Associate Director, Bioinformatics; Clinical Next-Generation Sequencing
  • Asia Pacific Session 1
    • Part 1: NGS in precision oncology - general education
    • Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population - a cost-effectiveness analysis
      OCT 22, 2020 12:05 PM SGT
      Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population - a cost-effectiveness analysis
      Aaron Tan, PhD
      Oncology Fellow, Resident Physician, National Cancer Centre, Singapore
    • The role of PARPis and HRD testing in advanced ovarian cancer
      OCT 22, 2020 12:25 PM SGT
      The role of PARPis and HRD testing in advanced ovarian cancer
      Natalie Ngoi, MBBS, MMed, MRCP
      Associate Consultant, National University Cancer Institute, Singapore
    • Part 2: Experiences with Oncomine Solutions for clinical research
    • OCA Plus DNA evaluation for comprehensive genomic profiling in clinical research
      OCT 22, 2020 1:15 PM SGT
      OCA Plus DNA evaluation for comprehensive genomic profiling in clinical research
      Ahwon Lee, MD, PhD
      Professor, Catholic University of Korea and Pathologist, Seoul St. Mary's Hospital
    • Latest Developments with the Genexus System
      OCT 22, 2020 1:35 PM SGT
      Latest Developments with the Genexus System
      Dr. Jose Luis Costa
      Medical Director, Thermo Fisher Scientific
  • Europe/North America Live Session 2
    • Part 1: Experiences with Oncomine Solutions for clinical research Part 1
    • The value of the Genexus System in pathology extended for use in SARS-CoV-2 sequencing
      APR 29, 2021 3:00 PM CEST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      The value of the Genexus System in pathology extended for use in SARS-CoV-2 sequencing
      Nicola Normanno, MD
      Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
      Continuing Education: Florida CE | P.A.C.E. CE
    • Part 1: NGS in precision oncology - general education
    • NGS for precision oncology in solid tumors: from research to clinical practice
      OCT 22, 2020 3:05 PM CEST
      NGS for precision oncology in solid tumors: from research to clinical practice
      Nicola Normanno, MD
      Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
    • Part 2: Experiences with Oncomine Solutions for clinical research
    • Next Generation rEvolution in Myeloid Neoplasms clinical research
      OCT 22, 2020 3:35 PM CEST
      Next Generation rEvolution in Myeloid Neoplasms clinical research
      Giada Rotunno, PhD
      Research Scientist, University of Florence
    • NGS evolution in Solid Tumours, from S5-XL to Genexus
      OCT 22, 2020 4:20 PM CEST
      NGS evolution in Solid Tumours, from S5-XL to Genexus
      Javier Hernandez-Losa, PhD
      Director of Molecular Biology Laboratory, Department of Pathology - Vall d´Hebron Hospital
    • First Experiences with Oncomine™ Comprehensive Assay Plus for comprehensive genomic profiling
      OCT 22, 2020 4:40 PM CEST
      First Experiences with Oncomine™ Comprehensive Assay Plus for comprehensive genomic profiling
      Ines Raineri, MD
      Staff Pathologist, Institute for Pathology medica AG
    • Part 2: Experiences with Oncomine Solutions for clinical research Part 2
    • NSCLC molecular profiling: An NGS based approach using Oncomine Solutions
      APR 29, 2021 3:35 PM CEST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      NSCLC molecular profiling: An NGS based approach using Oncomine Solutions
      Artur Kowalik, Ph.D.
      Head of Department of Molecular Diagnostics, Holycross Cancer Center
    • TBD
      APR 29, 2021 4:20 PM CEST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      TBD
      Speaker First & Last Name, Credentials
      Job Title, Institution/Company
    • TBD
      APR 29, 2021 4:40 PM CEST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      TBD
      Speaker First & Last Name, Credentials
      Job Title, Institution/Company
  • North America/Australia Live Session 3
    • Part 1: NGS in precision oncology - general education
    • Molecular Testing of NSCLC Biopsies: Making mountains out of molehills
      OCT 22, 2020 12:05 PM PDT
      Molecular Testing of NSCLC Biopsies: Making mountains out of molehills
      Carmen Kletecka, MD, FCAP, FASCP
      Medical Director, Molecular Oncology Diagnostics Laboratory - U.S. Department of Veterans Affairs
    • Clinical impact of Next-Generation Sequencing (NGS) Testing: A hematopathologist's perspective
      OCT 22, 2020 12:25 PM PDT
      Clinical impact of Next-Generation Sequencing (NGS) Testing: A hematopathologist's perspective
      Megan S. Lim, MD, PhD
      Director of the Division of Hematopathology, Hospital of the University of Pennsylvania
    • Part 2: Experiences with Oncomine Solutions for clinical research
    • Utilizing the Genexus System to Detect Complex Genetic Variants in Human Tissue Specimens
      OCT 22, 2020 1:15 PM PDT
      Utilizing the Genexus System to Detect Complex Genetic Variants in Human Tissue Specimens
      Craig Mackinnon, MD, PhD
      Director, Genomic Diagnostics and Bioinformatics - Professor, Department of Pathology, University of Alabama at Birmingham
    • Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
      OCT 22, 2020 1:35 PM PDT
      Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
      Jane Bayani, PhD
      Principal Research Scientist, Ontario Institute for Cancer Research
  • America's Live Session 3
    • Part 2: Experiences with IVD solutions for clinical research
    • Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
      APR 29, 2021 1:15 PM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
      Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
      Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
C.E. Credits

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


Help

General Labroots Questions

email support@labroots.com  

Virtual Events and Webinars

Supported Configurations

  • Operating System Internet Explorer Firefox Chrome Safari
    Vista IE8+ FF10+ Chrome15+
    Windows 7 IE8+ FF10+ Chrome15+
    Windows 8 IE10 FF10+ Chrome15+
    Mac OS X   FF10+ Chrome15+ Safari5.1+
  • Cookie settings: session cookies enabled
  • Browser configuration must have JavaScript enabled
  • Adobe Flash player 10.2 or later

To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

Internet Connection

  • A minimum of 100Kbps is recommended for audio-only events
  • A minimum of 300Kbps is recommended for speaker on-video events

Computer Equipment

  • Screen Resolution: Minimum 1024x768
  • Video Card: 65,000 colors minimum
  • Sound card and speakers (or headphones) for hearing webcast in full format
  • Audio Card: 16-bit minimum
  • RAM: 512MB of free RAM

Firewall Protocol

  • HTTP on port 80 or HTTPS on port 443
  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

Work-At-Home Attendees

  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

For A Seamless Experience

When using a mobile device, FREE Mobile Apps are available:

- For viewing Webinars:

- For viewing Virtual Events

Attendee Guide

  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

Virtual Event and Webinar Support:

Continuing Education (CME/CE) Support

Demographics

Specialty

Cancer

Molecular Genetics

Molecular Diagnostics

Molecular Biology

Cancer Research

Research And Development

Genetics

Personalized Medicine

Gene

Research

Cancer Diagnostics

Genomics

Human Genetics

Oncology

Clinical Medicine

Geography

North America34%

Europe26%

Asia25%

South America5%

Africa4%

Oceania2%

Registration Source

Website Visitors90%

Labroots Registration (Also interested in)6%

Social Media Promotions1%

Job Title

Executive11%

Facility/Department Manager11%

Research Scientist10%

Student9%

Medical Doctor/Specialist8%

Educator/Faculty8%

Scientist7%

Lab Management6%

Marketing/Sales5%

Biologist5%

Medical Laboratory Technician5%

Clinical Laboratory Scientist4%

Pathologist4%

Post Doc3%

Consultant3%

Engineer1%

Organization

Academic Institution22%

Hospital14%

Biotech Company11%

Clinical Laboratory8%

Life Science Company6%

Research Institute4%

Diagnostic Company3%

Government3%

Distribution/sales3%

Pharmaceutical Company2%

Consultant2%

Medical Center1%

Government/public1%

Medical School1%

Other5%

Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds
Attendees
  • See more